#pharmaceutical-research
#pharmaceutical-research

[ follow ]

Beyond Ozempic: New weight loss drug rivals surgery

Tufts researchers are creating a four-hormone weight loss drug aiming for greater efficacy and reduced side effects compared to existing options.

Zepbound shows superior weight loss compared to Wegovy in a recent clinical trial, influencing treatment decisions for obesity management.

Federal Circuit overturned injunction, allowing Avadel to conduct pre-approval activities for Lumryz under Hatch-Waxman 'safe harbor'.

AI has the potential to greatly enhance the drug discovery process by addressing the challenges of cost and time.

[ Load more ]